Agenus Inc/ US00847G7051 /
2024-03-28 3:58:16 PM | Chg. +0.0134 | Volume | Bid3:58:57 PM | Ask3:58:57 PM | High | Low |
---|---|---|---|---|---|---|
0.5698USD | +2.41% | 1.17 mill. Turnover: 617,334.4940 |
0.5699Bid Size: 200 | 0.5729Ask Size: 8,000 | 0.5729 | 0.5505 |
GlobeNewswire
03-06
MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Meta...
GlobeNewswire
02-14
First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allo...
GlobeNewswire
01-18
Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic...
GlobeNewswire
01-03
Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer
GlobeNewswire
2023-11-03
MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in S...
GlobeNewswire
2023-10-11
Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The O...
GlobeNewswire
2023-08-31
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
GlobeNewswire
2022-03-07
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 S...
GlobeNewswire
2022-02-22
Sigilon Therapeutics Appoints Sarah Yuan, Ph.D., as Chief Technical Operations Officer
GlobeNewswire
2022-02-22
Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical Officer
GlobeNewswire
2022-02-15
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
GlobeNewswire
2021-12-22
Balstilimab Plus Zalifrelimab Data Published in Journal of Clinical Oncology (JCO)
GlobeNewswire
2021-11-12
Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITC
GlobeNewswire
2021-11-12
MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failur...
GlobeNewswire
2021-11-09
MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2...
GlobeNewswire
2021-11-09
Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas Series